Attention Deficit Hyperactivity Disorder
Daytrana proves effective for ADHD in children; offers shorter option for long-acting medication
Published in Drug Week, November 24th, 2006
Shire plc (SHP, SHPGY,SHQ) announced that its Attention Deficit Hyperactivity Disorder (ADHD) patch, DAYTRANA (methylphenidate transdermal system), has significant efficacy in reducing the symptoms of ADHD in children aged 6 to 12 years, even when the ADHD patch is taken off earlier than the recommended nine hours. The ability to remove the patch earlier than the recommended nine-hour wear time allows physicians the opportunity to manage the potential for late-day side effects, such as lack of appetite or difficulty sleeping. These phase IIIb clinical trial results were reported at a major scientific and educational meeting of child and adolescent psychiatrists in San Diego, Calif.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2006-11-24)
More Articles from Drug Week
- Attention Deficit Hyperactivity Disorder
Shire investigational drug SPD465 shown to reduce ADHD symptoms for up to 16 hours - Actinomycosis
Data on actinomycosis detailed by researchers at Karolinska University, Department of Odontology - Acute Kidney Failure Therapy
Scientists at McGill University, Department of Epidemiology describe research in acute kidney failure therapy - Anemia Risk Factors
Researchers at Chang-Gung University, Department of Internal Medicine target anemia risk factors - Angiogenesis
Recent studies from National Institutes of Health add new data to angiogenesis - Angiotensins
Researchers from University Hospital, Department of Internal Medicine publish new studies and findings in the area of angiotensins - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
